The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices.

The FTC says it doesn’t have enough active commissioners to move forward after President Donald Trump fired two Democrats last month.

The health sector is experiencing significant disruptions, with the FTC halting a lawsuit against pharmacy-benefit managers ...

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after President Trump fired two of the agency’s commissioners.

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the ...

Andrew Ferguson, the chair of the Federal Trade Commission, has decided to rejoin the agency’s lawsuit against major ... against CVS’ Caremark, Cigna’s Express Scripts and UnitedHealth ...

(Reuters) - The U.S. Federal Trade Commission's lawsuit against pharmacy benefit ... CVS Health's CVS Caremark and Cigna's Express Scripts could move forward. As Virginia's solicitor general ...

(Reuters) -The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth, Cigna and CVS Health over insulin prices after the Trump administration ...

The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and ...